VA Puget Sound Health Care System
Seattle, Washington, 98116, United States
NCT Number: NCT03191760
The purpose of the study is to see if "Behavioral Activation and Social Engagement for PTSD" (BASE for PTSD), an individual therapy for PTSD, will help Veterans with PTSD 1) through improved understanding of how PTSD affects them, 2) by reducing ways in which they avoid meaningful activity due to PTSD, 3) by enabling them to do more of the things they really care about, and 4) by improving, strengthening, and building up their social supports.
Looking for future studies?
Notify Me18 year and older
All sexes
Interventional
Not applicable
Seattle, Washington, 98116, United States
Posttraumatic stress disorder (PTSD) is a mental health condition that some people develop following exposure to a traumatic event. PTSD often results in a reduction in feelings of connection to other people and changes in views about others, as well as reduced participation in valued activities. Many veterans with PTSD do not seek treatment offered in specialty mental health settings and may forgo treatment of any kind.
This study is an open-trial format (no comparison condition) of U.S. military veterans who will participate in a brief psychotherapy treatment for PTSD offered in a Primary Care setting. This is a pilot trial to see if the treatment is effective at reducing symptoms of PTSD and increasing feelings of social support, and an exploratory aim is to see if veterans engage in additional treatment after completing this treatment.
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Participants will be asked to attend 6 in-person or phone-mediated therapy sessions lasting approximately 45 minutes per session, to be held in Primary Care settings. Content of therapy sessions includes education about PTSD symptoms, discussion of the role of avoidance in maintaining PTSD symptoms, self-monitoring homework to identify links between activity level and emotions, and homework designed to increase engagement in valued activities, with a focus on increasing social contact and support. If relevant, participants will be instructed in basic communication skills, social skills, and relaxation skills.
Time frame: baseline to 4 weeks, 4 weeks to 8 weeks, 8 weeks to 12 weeks
Change in PTSD symptoms
Time frame: baseline to 4 weeks, 4 weeks to 8 weeks, 8 weeks to 12 weeks
Change in social support
Time frame: baseline to 4 weeks, 4 weeks to 8 weeks, 8 weeks to 12 weeks
Change in Depression symptoms
Time frame: baseline to 4 weeks, 4 weeks to 8 weeks, 8 weeks to 12 weeks
Change in social network orientation
Time frame: baseline to 4 weeks, 4 weeks to 8 weeks, 8 weeks to 12 weeks
Change in activity level
Time frame: 12 weeks
Participants' reactions to the treatment will be gathered in qualitative interviews assessing treatment experience, perceptions of treatment focus, engagement with valued activities, social support, therapeutic relationship
Time frame: 16 weeks
measured via medical record review
Time frame: baseline to 4 weeks, 4 weeks to 8 weeks, 8 weeks to 12 weeks
Change in coping strategies
Time frame: baseline to 4 weeks, 4 weeks to 8 weeks, 8 weeks to 12 weeks
Change in the level of interpersonal closeness related to participants' social environment and the degree of difficulty experienced by participants in sustaining the sense of closeness
VA Puget Sound Health Care System
Fed
Acronym: PTSD
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT05512143
Cardiovascular Diseases, Hypertension
Providence, Rhode Island, United States
View Trial DetailsNCT03194386
Mental Disorders, Post-traumatic Stress Disorder
Bordeaux, France
View Trial DetailsNCT03519789
Mental Disorders, Post-traumatic Stress Disorder
Lille, France
View Trial DetailsNCT00739765
Anxiety Disorders, Mental Disorders
New York, United States
View Trial Details